Cytarabine Safety Questions, Cytarabine Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Cytarabine side effects. Check out Health Surveys and Health Polls. If you have questions about Cytarabine, you can post them to our Doctors or Ask Patient Community about Cytarabine.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Cytarabine
Cytarabine Safety Reports
Total Cytarabine reports: 281.Cytarabine FDA safety alerts: No.
Reported deaths: 61 Reported hospitalizations: 192.
Take Cytarabine Side Effects Survey or Share Your Cytarabine Story.
Reported Cytarabine Side Effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, blood culture positive, disease progression, hypotension, sepsis, white blood cell count decreased, diarrhoea haemorrhagic, pyrexia, haematocrit decreased.
Cytarabine Usage.
Showing 1-50 of 281 Next >
Cytarabine Side Effects Report #5286000-0Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Mar 15, 2007. Male patient, 73 years of age, weighting 179.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, atrial fibrillation, body temperature increased, electrocardiogram qt prolonged, haematocrit decreased, haemoglobin decreased, platelet count decreased, refusal of treatment by patient, respiratory arrest. CYTARABINE dosage: 2000 MG QD X 5 IV. During the same period patient was treated with BENADRYL, LASIX, SEVELAMER, PREVASTATIN, NYSTATIN, FLOMAX. Patient died.
Cytarabine Side Effects Report #5286038-3
CYTARABINE problem was reported by a Health Professional from UNITED STATES on Mar 22, 2007. Male patient, 67 years of age, weighting 207.5 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, cerebral haemorrhage, disease progression, haemoglobin decreased, subarachnoid haemorrhage, thrombocytopenia, white blood cell count decreased. CYTARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, MITOXANTRONE. Patient died on 01/10/2007.
Cytarabine Side Effects Report #5286925-6
Consumer or non-health professional from RUSSIAN FEDERATION reported CYTARABINE problem on Mar 19, 2007. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: toxic shock syndrome. CYTARABINE dosage: 20 MG/M2, UNK; SC. During the same period patient was treated with AMPHOTERICIN B, NITROMETHASONE, ERYTHROMYCIN, CEFOTAXIME, BROMHEXINE, LASIX, VERAPAMIL. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5286926-8
CYTARABINE problem was reported by a Health Professional from AUSTRALIA on Mar 23, 2007. Female patient, 82 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: decreased appetite, diarrhoea, disease progression, hypotension, lethargy, malaise, pallor, skin turgor decreased. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. Patient was hospitalized. Patient died on 02/23/2007.
Cytarabine Side Effects Report #5288029-5
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Feb 24, 2007. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, asthenia, atrial fibrillation, bradycardia, cardiac arrest, epistaxis, febrile neutropenia, gastrointestinal haemorrhage, haematocrit decreased. CYTARABINE dosage: 20 MG/M2 QD SC. Patient was hospitalized. Patient died on 09/30/2006.
Cytarabine Side Effects Report #5290062-4
CYTARABINE problem was reported by a Health Professional from CANADA on Mar 23, 2007. Male patient, 84 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, febrile neutropenia, immunosuppression. CYTARABINE dosage: 20 MG/M2 QD SC. During the same period patient was treated with TAPAZOLE, OMEPRAZOLE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5290063-6
Health Professional from CANADA reported CYTARABINE problem on Mar 23, 2007. Male patient, 69 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood culture positive, febrile neutropenia, haematocrit decreased, haemoglobin decreased, platelet count increased, streptococcal infection, white blood cell count decreased. CYTARABINE dosage: 20 MG/M2 PER_CYCLE SC. During the same period patient was treated with ISONIAZID, VITAMIN B6, SYNTHROID. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5290064-8
CYTARABINE problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Mar 23, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, haemoglobin decreased, lymphadenopathy, parapharyngeal abscess, pneumonia, red blood cell count decreased, white blood cell count decreased. CYTARABINE dosage: 20 MG DAILY SC. During the same period patient was treated with NYSTATIN, RIFATAR, ETHAMBUTOL HYDROCHLORIDE, VITAMIN B6. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5289277-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 04, 2007. Male patient, weighting 269.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, ejection fraction decreased, pulmonary embolism, ventricular dysfunction. CYTARABINE dosage: 42480 MG. During the same period patient was treated with ARANESP. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5289279-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 04, 2007. Female patient, weighting 97.44 lb, was treated with CYTARABINE. CYTARABINE dosage: 910 MG. Patient died on 11/24/2004.
Cytarabine Side Effects Report #5290550-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 05, 2007. Male patient, weighting 211.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anorexia, ascites, blood creatinine increased, bone marrow failure, cardiac arrest, cardiomegaly, chills, diarrhoea, gallbladder disorder. CYTARABINE dosage: 1498 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5290562-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, weighting 162.9 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dialysis, renal failure acute, sepsis. CYTARABINE dosage: 3100MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE, TOBRAMYCIN, VANCOMYCIN, VORICONAZOLE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5291800-7
Health Professional from UNITED STATES reported CYTARABINE problem on Mar 23, 2007. Male patient, 68 years of age, was diagnosed with myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dialysis, hyperbilirubinaemia, hypotension, renal failure, renal tubular necrosis, sepsis, tumour lysis syndrome. CYTARABINE dosage: 2020 MG QD X 5 IV. During the same period patient was treated with AMBISOME. Patient died on 03/21/2007.
Cytarabine Side Effects Report #5292075-5
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 06, 2007. Female patient, weighting 349.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression. CYTARABINE dosage: 1260 MG; 180 MG IV OVER 24 HRS X 7 DAYS. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient recovered.
Cytarabine Side Effects Report #5299690-3
Consumer or non-health professional from FRANCE reported CYTARABINE problem on Mar 16, 2007. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: disease progression, disseminated intravascular coagulation, sepsis. CYTARABINE dosage: 20 MG/M2 PER_CYCLE IV. Patient died.
Cytarabine Side Effects Report #5299723-4
CYTARABINE problem was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Mar 26, 2007. Female patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, febrile neutropenia, lymphadenectomy, oral candidiasis. CYTARABINE dosage: 28 MG PER_CYCLE SC. During the same period patient was treated with RIFATAR, ETHAMBUTOL HYDROCHLORIDE, VITAMIN B6, NYSTATIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5299724-6
Consumer or non-health professional from ROMANIA reported CYTARABINE problem on Mar 26, 2007. Female patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: infection in an immunocompromised host, pancytopenia, pleural effusion, pneumonia. CYTARABINE dosage: 20 MG/M2. During the same period patient was treated with PREDNISONE, METOPROLOL SUCCINATE, FAMOTIDINE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5302164-4
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 213.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: chest pain, dyspnoea, ecg signs of myocardial ischaemia, hypotension, procedural complication. CYTARABINE dosage: 1470 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5302911-1
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 19, 2007. Male patient, weighting 162.9 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, dialysis, renal failure acute, sepsis. CYTARABINE dosage: 3110 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE, TOBRAMYCIN, VANCOMYCIN, VORICONAZOLE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5305859-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 20, 2007. Male patient, weighting 195.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood creatinine increased, blood urea increased, haemodialysis, haemoglobin decreased, mouth haemorrhage, obstructive airways disorder, oliguria. CYTARABINE dosage: 1400 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5306010-4
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 20, 2007. Male patient, weighting 195.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood creatinine increased, blood urea increased, haemodialysis, haemoglobin decreased, mouth haemorrhage, obstructive airways disorder, oliguria. CYTARABINE dosage: 1400 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5306447-3
CYTARABINE problem was reported by a Health Professional from RUSSIAN FEDERATION on Apr 03, 2007. Female patient, 68 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: autoimmune disorder, haemodialysis, multi-organ failure, renal failure, toxic shock syndrome. CYTARABINE dosage: 35 MG QD SC. During the same period patient was treated with CEFTAZIDIME, AMPHOTERICN, METOCLOPRAMIDE. Patient died on 03/30/2007.
Cytarabine Side Effects Report #5307238-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 23, 2007. Male patient, weighting 195.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood creatinine increased, blood urea increased, haemodialysis, haemoglobin decreased, mouth haemorrhage, obstructive airways disorder, oliguria. CYTARABINE dosage: 1400 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5307240-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Female patient, weighting 56.22 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, alpha haemolytic streptococcal infection, ascites, cardiac failure congestive, disseminated intravascular coagulation, fluid overload, hepatic failure, hypotension, left ventricular dysfunction. CYTARABINE dosage: 7840 MG. During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5313390-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 27, 2007. Male patient, weighting 209.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bacterial infection, blood culture positive, cardiac disorder, cellulitis, dyspnoea, haematuria, hypertension, hypoxia, infusion site reaction. CYTARABINE dosage: 1470 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5314243-6
CYTARABINE problem was reported by a Physician from UNITED STATES on Apr 10, 2007. Female patient, 73 years of age, was diagnosed with myeloid leukaemia, neutropenia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, hidradenitis. CYTARABINE dosage: unknown. During the same period patient was treated with NEUPOGEN, IDARUBICIN. Patient recovered.
Cytarabine Side Effects Report #5315652-1
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Apr 30, 2007. Female patient, weighting 56.22 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, antithrombin iii decreased, ascites, cardiac failure congestive, disseminated intravascular coagulation, ejection fraction decreased, fluid overload, hepatic failure, hypotension. CYTARABINE dosage: 7840 MG (980 MG IV Q12 HRS X 4 DAYS). During the same period patient was treated with MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5316623-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 30, 2007. Male patient, weighting 173.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: neutropenic sepsis, platelet count decreased, tachycardia, white blood cell count decreased. CYTARABINE dosage: 4000 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5316718-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 01, 2007. Male patient, weighting 145.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: haemothorax, post procedural haemorrhage. CYTARABINE dosage: 1218 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5318572-1
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, weighting 231.5 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, dyspnoea, hyperhidrosis, malaise, pain. CYTARABINE dosage: 460 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5318918-4
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 04, 2007. Male patient, weighting 195.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, blood creatinine increased, blood urea increased, haemodialysis, haemoglobin decreased, mouth haemorrhage, obstructive airways disorder, oliguria. CYTARABINE dosage: 1400 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5318922-6
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 04, 2007. Male patient, weighting 195.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: carotid artery occlusion, cavernous sinus thrombosis, hypotension, iiird nerve paralysis, loss of consciousness, mass, mucormycosis, neutropenia. CYTARABINE dosage: 1400 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5321265-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 07, 2007. Male patient, weighting 145.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: haemothorax, pleural effusion, post procedural complication. CYTARABINE dosage: 1218 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5321927-2
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 08, 2007. Male patient, weighting 155.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: back pain, loss of consciousness, neuropathy. CYTARABINE dosage: 680 MG. During the same period patient was treated with DEXAMETHASONE, ETOPOSIDE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 04/28/2007.
Cytarabine Side Effects Report #5328399-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 15, 2007. Male patient, weighting 149.9 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, abdominal pain, back pain, cardiac arrest, cyanosis, hypotension, hypoxia, intervertebral disc protrusion, intervertebral discitis. CYTARABINE dosage: 680 MG. During the same period patient was treated with DEXAMETHASONE, ETOPOSIDE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient died on 04/29/2007.
Cytarabine Side Effects Report #5334413-0
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2007. Female patient, weighting 256.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: acidosis, ammonia increased, aspergillosis, blood culture positive, brain oedema, caecitis, colitis, gastroenteritis escherichia coli, gastrointestinal necrosis. CYTARABINE dosage: 70 MG. During the same period patient was treated with DAUNORUBICIN, METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, INSULIN, LAXATIVE, NEXIUM. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5336312-7
Health Professional from UNITED STATES reported CYTARABINE problem on May 11, 2007. Female patient, 55 years of age, weighting 185.2 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, febrile neutropenia, immunosuppression. CYTARABINE dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5336710-1
CYTARABINE problem was reported by a Pharmacist from UNITED STATES on May 24, 2007. Male patient, 48 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pyrexia. CYTARABINE dosage: unknown. During the same period patient was treated with FILGRASTIM. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5336898-2
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 24, 2007. Female patient, weighting 158.3 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: torsade de pointes, ventricular fibrillation. CYTARABINE dosage: 177 MG. During the same period patient was treated with DAUNORUBICIN, MYLOTARG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5337462-1
CYTARABINE problem was reported by a Physician from FRANCE on May 14, 2007. Female patient, 53 years of age, was diagnosed with meningeal disorder and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: aphasia, vasculitis cerebral. CYTARABINE dosage: 50 MG;X1;INTH. During the same period patient was treated with METHOTREXATE, CORTICOSTEROIDS. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5337958-2
Health Professional from JAPAN reported CYTARABINE problem on May 23, 2007. Female patient, 61 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blast cell count increased, cerebral haemorrhage. CYTARABINE dosage: unknown. During the same period patient was treated with IMATINIB MESYLATE. Patient died.
Cytarabine Side Effects Report #5339674-X
CYTARABINE problem was reported by a Health Professional from UNITED STATES on May 16, 2007. Female patient, 65 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, decubitus ulcer, deep vein thrombosis, neurotoxicity, pneumonia cytomegaloviral. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, DEPOCYT, FRACTIONATED CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN. Patient recovered.
Cytarabine Side Effects Report #5339678-7
Health Professional from UNITED STATES reported CYTARABINE problem on May 16, 2007. Female patient, 42 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, convulsion, faecal incontinence, hypoaesthesia, neurotoxicity, papilloedema, urinary hesitation. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, DEPOCYT, FRACTIONATED CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE, NEUPOGEN, ANTIBIOTICS. Patient recovered.
Cytarabine Side Effects Report #5339691-X
CYTARABINE problem was reported by a Health Professional from UNITED STATES on May 16, 2007. Female patient, 19 years of age, was diagnosed with b-cell type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: benign intracranial hypertension, neurotoxicity, visual acuity reduced. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, DEPOCYT, FRACTIONATED CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE. Patient recovered.
Cytarabine Side Effects Report #5339693-3
Health Professional from UNITED STATES reported CYTARABINE problem on May 16, 2007. Male patient, 22 years of age, was diagnosed with b precursor type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: complex partial seizures, convulsion, neurotoxicity. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, DEPOCYT, FRACTIONATED CYCLOPHOSPHAMIDE, VINCRISTINE, DOXORUBICIN, DEXAMETHASONE. Patient recovered.
Cytarabine Side Effects Report #5339703-3
CYTARABINE problem was reported by a Physician from UNITED STATES on May 16, 2007. Male patient, 54 years of age, was diagnosed with b precursor type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: encephalitis, neurotoxicity. CYTARABINE dosage: unknown. During the same period patient was treated with METHOTREXATE, DEPOCYT, VINCRISTINE, CYCLOPHOSPHAMIDE, DOXORUBICIN, DEXAMETHASONE, RITUXIMAB, NEUPOGEN. Patient died.
Cytarabine Side Effects Report #5341037-8
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on May 14, 2007. Male patient, 42 years of age, weighting 140.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, acute respiratory distress syndrome, acute respiratory failure, bacterial infection, blood creatinine increased, blood culture positive, blood ph decreased, blood urea decreased, clostridium difficile colitis. CYTARABINE dosage: unknown. During the same period patient was treated with MITOXANTRONE, ETOPOSIE. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5341976-8
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 30, 2007. Male patient, weighting 182.1 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: escherichia sepsis, hypotension, neutropenia, respiratory failure. CYTARABINE dosage: 34740 MG. Patient was hospitalized. Patient recovered.
Cytarabine Side Effects Report #5343594-4
Physician from CANADA reported CYTARABINE problem on May 22, 2007. Female patient, child 7 years of age, was diagnosed with b precursor type acute leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: aphasia, brain oedema, cerebrovascular spasm, coagulopathy, encephalopathy, hallucination, visual, hemiparesis, incontinence, reversible posterior leukoencephalopathy syndrome. CYTARABINE dosage: 70 MG PER_CYCLE IT. During the same period patient was treated with DEXAMETHASONE, VINCRISTINE, METHOTREXATE. Patient recovered.
Cytarabine Side Effects Report #5344211-X
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on May 31, 2007. Male patient, weighting 176.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: dyspnoea exertional, haematocrit decreased, haemoglobin decreased, palpitations. CYTARABINE dosage: 35400 MG. Patient was hospitalized. Patient recovered.
Showing 1-50 of 281 Next >